4D MOLECULAR THERAPEUTICS IN
FDMT · NASDAQ
Updated at 2026-10-15 04:54:16
- Today's High
- $12.58
- Today’s Low
- $11.99
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $12.18
- Previous Close
- $12.20
- Volume
- 632.96K
- Market Cap
- $718.17M
- P/E Ratio
- --
- EPS
- $-2.75
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 5858 HORTON STREET, EMERYVILLE, CA, UNITED STATES, 94608
- Country
- US
- Listing Date
- 2020-12-11
- Fiscal Year End
- December
- Shares Outstanding
- 52.28M
- CIK
- 0001650648
- Website
- 4dmoleculartherapeutics.com
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops candidate products using its adeno-associated virus vectors. The company is headquartered in Emeryville, California.
Financial Metrics
Revenue
2026-06-30
$3.78M
2026-03-31
$3.04M
2025-12-31
$85.09M
2025-09-30
$90K
Operating Expenses
2026-06-30
$78.71M
2026-03-31
$74.61M
2025-12-31
$68.39M
2025-09-30
$14.03M
Net Income
2026-06-30
-$72.93M
2026-03-31
-$68.76M
2025-12-31
$19.39M
2025-09-30
-$56.87M
Net Profit Margin
2026-06-30
-1.92K%
2026-03-31
-2.25K%
2025-12-31
22.79%
2025-09-30
-63.19K%
Earnings Per Share
2026-06-30
$-1.04
2026-03-31
$-1.01
2025-12-31
$0.43
2025-09-30
$-1.01
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$74.77M
2026-03-31
-$66.7M
2025-12-31
$12.38M
2025-09-30
-$54.87M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $3.78M | $3.04M | $85.09M | $90K |
| Operating Expenses | $78.71M | $74.61M | $68.39M | $14.03M |
| Net Income | -$72.93M | -$68.76M | $19.39M | -$56.87M |
| Net Profit Margin | -1.92K% | -2.25K% | 22.79% | -63.19K% |
| Earnings Per Share | $-1.04 | $-1.01 | $0.43 | $-1.01 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$74.77M | -$66.7M | $12.38M | -$54.87M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.